Research and innovation in the development of everolimus for oncology

Author： Lebwohl David Thomas George Lane Heidi A O'Reilly Terence Escudier Bernard Yao James C Pavel Marianne Franz David Berg William Baladi Jean-Francois Stewart Jubilee Motzer Robert J

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.6, Iss.3, 2011-03, pp. : 323-338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Open innovation: the new face of pharmaceutical research and development

By Getz Kenneth A Kaitin Kenneth I

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 5, 2012-09 ,pp. : 481-483

Informa Healthcare

Access to resources Recommend Favorite

China as a Growing Research Base for Innovation in Medicines Development

By Humphries Michael

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 6, 2006-01 ,pp. : 355-359

Adis International

Access to resources Recommend Favorite

Everolimus

By Chapman T.M. Perry C.M.

Drugs, Vol. 64, Iss. 8, 2004-01 ,pp. : 861-872

Adis International

Access to resources Recommend Favorite

The Quickening Pace of Oncology Research

By Winn Rodger J.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 4, 2004-07 ,pp. : 269-270

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

The development of erythropoietic agents in oncology

By Glaspy John A

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 3, 2005-08 ,pp. : 553-567

Informa Healthcare

Access to resources Recommend Favorite